Press Releases

Date Title and Summary
Toggle Summary United Kingdom's NHS Supply Chain to Acquire Seven TomoTherapy® Systems
Largest Ever Accuray Deal Will Provide More Cancer Patients in the United Kingdom (UK) Access to Advanced, Precise Radiation Treatments SUNNYVALE, Calif. , June 16, 2016 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) has a signed deal with NHS Supply Chain for seven TomoTherapy® Systems in a
Toggle Summary University Hospital Città della Salute e della Scienza, Turin, Italy is First in EIMEA to Treat Cancer Patients Using the Accuray Radixact® System with Synchrony® Technology
Renowned Hospital in Turin, Italy Uses Innovative Radiation Therapy Delivery System to Expand Options for Advanced Cancer Care to More Patients SUNNYVALE, Calif. , Sept. 1, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at University Hospital
Toggle Summary Vicenza Hospital Becomes First European Facility to Purchase Its Second CyberKnife System
New Unit Will Enable Italian Hospital to Expand Radiosurgery to Treat Lung and Prostate Cancer SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Vicenza Hospital, Ospedale Civile San Bortolo
Toggle Summary West Coast Cancer Center Breaks Ground on New Building to House CyberKnife System
SUNNYVALE, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the Comprehensive Blood and Cancer Center (CBCC) -- one of the nation's largest freestanding, physician owned and operated comprehensive
Toggle Summary Widespread Acceptance and Use of Accuray's Technologies Continue to Grow
More than 700 CyberKnife® and TomoTherapy® Systems Have Treated More Than Half a Million Patients Worldwide SUNNYVALE, Calif. , Nov. 25, 2013 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in global adoption of its CyberKnife® and TomoTherapy® Systems.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.